Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Flextronics International Ltd.

Latest From Flextronics International Ltd.

Pelikan Swoops in on the Big Four

Following the strategy of those icons of success in the diabetes industry, Medisense and Therasense, Pelikan Technologies is executing well on its plan to develop a glucose monitoring platform that offers convience and freedom from pain, to reduce the current hurdles that prevent patients with diabetes from testing as much as they should. (Part of a group of articles that includes: "Where are They Now? Checking in on Three Glucose Monitoring Companies," "A Decade of Development of SMSI: Will it Yield Improved Accuracy in CGM?" and "GlucoLight: Making Non-Invasive Glucose Monitoring Real."
Medical Device Platform Technologies
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Southeast Asia
        • Singapore
  • Parent & Subsidiaries
  • Flextronics International Ltd.
  • Senior Management
  • Michael McNamara, CEO
    Christopher Collier, CFO
    Ruvi Shaibel, Pres, Strategic Partnerships
    Michael Mendenhall, Chief Marketing & Communications Officer
  • Contact Info
  • Flextronics International Ltd.
    Phone: (65)
    2 Changi South Lane
    Singapore, 486123